Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Matthias Will, M.D., as Chief ...

Plant scientists have identified a protein that plays a previously unknown role in controlling cell differentiation and determining gender in vascular plants, using a fern model. The discovery ...

The ID3 gene maintains FOXP3 expression, which is necessary for maintaining the suppressive function of regulatory T cells. The PRDM1 gene encodes the B lymphocyte–induced maturation protein–1 ...

Elevated sodium levels in tumors boost T-cell metabolic fitness and cytotoxicity, revealing potential avenues for improving ...

Cema-cel, the company’s flagship therapy, is in a pivotal Phase 2 trial (ALPHA3) for large B-cell lymphoma, with potential regulatory submission by 2027. Despite a promising pipeline ...

Legislation enabling people to work in Virginia with occupational licenses from other states has brought nearly 600 to work ...

Their rise has not been without controversy. Notably, stablecoins face scrutiny over their transparency, regulatory compliance with KYC and AML, and underlying technical mechanisms. In May of 2022 ...

Merck and Daiichi Sankyo said a Phase 3 study evaluating patritumab deruxtecan in patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer who received prior EGFR tyrosine ...

EU regulator backs use of Novo's Wegovy for obesity-related heart condition The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people ...

The company is now seeking partnership funding to launch a pivotal Phase II/III study of the autologous T-regulatory cell therapy.

A case involving the vape industry gives the U.S. Supreme Court a chance to further erode the authority of federal regulatory agencies following other major rulings as the justices gird for a new ...